Anti-CD2 monoclonal antibody B-E2

Drug Profile

Anti-CD2 monoclonal antibody B-E2

Alternative Names: B-E2 monoclonal antibody

Latest Information Update: 19 Feb 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Diaclone Research; OPi
  • Developer Diaclone Research; Nonindustrial source
  • Class Monoclonal antibodies
  • Mechanism of Action CD2 antigen inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Graft-versus-host disease

Most Recent Events

  • 14 Dec 1995 Investigation in Graft-versus-host disease in France (IV-infusion)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top